High impact
MAb2026063002
Pennsylvania Medicaid (DHS)·Effective Jul 6, 2026
Pennsylvania Medical Assistance (MA) program updated prior authorization requirements for antipsychotic medications effective July 6, 2026. New guidelines require prior auth for non-preferred antipsychotics, pediatric prescriptions (under 18), quantity limits exceeded, and therapeutic duplication. Clinical review now mandates FDA-approved or medically accepted indications, appropriate dosing per FDA labeling or peer-reviewed literature, and for children, comprehensive evaluation, specialist involvement, and baseline metabolic monitoring documentation.